Amgen (AMGN) Tops Q3 EPS by 47c; offers guidance
Tweet
Share
E-mail
Get Alerts AMGN Hot Sheet
Price: $347.01 +0.66%
EPS Growth %: -7.1%
Financial Fact:
Research and development: 990M
Today's EPS Names:
CBRS, MAYS, CRMT, More
EPS Growth %: -7.1%
Financial Fact:
Research and development: 990M
Today's EPS Names:
CBRS, MAYS, CRMT, More
Join SI Premium – FREE
Amgen (NASDAQ: AMGN) reported Q3 EPS of $5.58, $0.47 better than the analyst estimate of $5.11. Revenue for the quarter came in at $8.5 billion versus the consensus estimate of $8.51 billion.
GUIDANCE:
Amgen sees FY2024 EPS of $19.20-$20.00, versus the consensus of $19.51. Amgen sees FY2024 revenue of $33-33.8 billion, versus the consensus of $33.2 billion.
For earnings history and earnings-related data on Amgen (AMGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cerebras Systems (CBRS) Misses Q1 EPS, Revenues Beat
- Bernstein SocGen Group Reiterates Outperform Rating on Hermes International (RMS:FP) (HESAY) after cautious commentary
- MSCI upgrades Bulgaria to Frontier, flags Indonesia and Turkey risks
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
